Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220018162 220009572 1.77 72 Curative (C) 2015-08-02 2016-01-01 Capecitabine + Oxaliplatin 21day N N 220036413 SPIRIT TRIAL
220018163 220009575 null 80 Curative (C) 2012-09-17 2013-05-16 Spanish Maintenance (Months 4-24) null null 220036427 SORAFENIB
220018164 220009576 null null Curative (C) 2016-03-09 2016-08-11 DA-EPOCH-R N N 220036432 METHOTREXATE HIGH DOSE
220018165 220009584 1.62 65.8 Palliative (P) 2016-12-29 2017-02-13 CYTARABINE + ETOPOSIDE 2 N 220036441 IBRUTINIB
220018167 220009586 1.95 null Palliative (P) 2013-11-07 2014-07-22 METHOTREXATE + PEGASPARGASE 2 N 220036446 CAPECITABINE + OXALIPLATIN
220018168 220009586 1.68 73.1 Disease modification (D) 2017-09-15 2017-09-20 Busulfan + Cyclophos Conditioning N N 220036446 BUSULPHAN + CYCLO
220018170 220015081 0 54.1 Palliative (P) 2013-06-30 2013-07-01 GCLAC 02 Y 220036472 CYCLOPHOSPHAMIDE + LENALIDOMIDE
220018171 220015081 null 94.2 Curative (C) null 2013-09-25 Arsenic Triox + Tretinoin Ind W1-4 N null 220036472 VINORELBINE
220018172 220009592 1.68 76 Curative (C) 2018-01-09 2018-03-31 MACE N null 220036485 VINCRISTINE
220018173 220018224 1.5 66.1 Curative (C) 2014-06-24 2014-12-09 Capecitabine (21 day) + Irinotecan N N 220036486 CLOFARABINE + CYTSARABINE + IDARUBICIN
220018174 220009594 1.56 null null 2017-03-01 2017-03-14 VINORELBINE N N 220036524 ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE
220018175 220015084 1.75 100.5 Palliative (P) 2017-03-15 2017-09-01 ALL UKALL2011 Maintenance A3 02 N 220036533 CISPLATIN + PEMETREXED
220018176 220009601 1.63 -1 Palliative (P) 2014-12-15 2014-12-18 PEMBROLIZUMAB null null 220036542 IVE
220018178 220009606 1.7 108 null 2015-03-31 2018-03-27 Bortezomib +/- Dexamethasone N N 220036563 CHOP R
220018179 220009609 null null Palliative (P) 2014-01-15 2014-01-17 DHAP N N 220036575 CYCLOPHOSPHAMIDE HIGH DOSE
220018180 220009612 1.68 null Curative (C) null 2018-08-31 Cladribine (subcut) 5 days N N 220036586 INTERFERON
220018181 220009614 null null Curative (C) 2016-11-09 2016-11-11 DTPACE N N 220036590 FIGARO TRIAL
220018182 220009618 1.65 71.8 Palliative (P) 2014-04-14 2014-04-19 Topotecan (intravenous) N N 220036606 INTERFERON
220018183 220009624 1.85 63.6 Adjuvant (A) 2015-10-14 2015-11-25 ATG + Busulfan + Fludarabine + Thiotepa 2 N 220036614 ARSENIC TRIOXIDE + ATRA
220018184 220015093 2 97 Palliative (P) 2012-09-26 2012-10-10 ALL Int Guide A/B/C Maint Ph V 2 N 220036619 ARSENIC TRIOXIDE + ATRA
220018185 220009629 1.69 null Disease modification (D) 2016-05-31 2017-08-16 ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE + MELPHALAN 02 N 220036629 EOX
220018186 220009633 null 15.05 Curative (C) 2014-10-30 2014-10-30 Alemtuzumab+Busulfan+CyclophosphMUD null N 220036632 CTD
220018187 220009635 null null Palliative (P) 2015-12-17 2017-04-25 FLUDARABINE N N 220036633 GEMCITABINE + PACLITAXEL
220018188 220009638 null 101.699 Adjuvant (A) 2016-01-19 2016-01-25 DOCETAXEL + PERTUZUMAB + TRASTUZUMAB N N 220036640 FEC
220018189 220009640 null 51.1 Palliative (P) 2014-11-04 2014-11-10 SPANISH MAINTENANCE 2 N 220036641 MIDAC
220018190 220009648 1.62 66 Curative (C) 2017-04-28 2017-04-28 LENALIDOMIDE N N 220036653 CYTARABINE + FLUDARABINE
220018191 220015095 null null Palliative (P) 2013-12-20 2015-07-29 Capecitabine null null 220036654 IVE
220018193 220009655 1.68 120 Disease modification (D) 2018-02-09 2018-02-14 BUSULFAN + FLUDARABINE N null 220036675 CYTARABINE IT + METHOTREXATE
220018194 220009659 null 13.9 Not known (9) 2017-11-25 2017-11-25 ALL UKALL2011 Maintenance A1 null N 220036683 CETUXIMAB
220018195 220015102 1.72 88 Curative (C) 2018-06-23 2018-07-06 VINCRISTINE N N 220036725 CYTARABINE + FLUDARABINE + IDARUBICIN
220018196 220009667 1.61 null Palliative (P) 2015-08-12 2015-08-26 Sunitinib N N 220036733 UKALL2011
220018197 220009668 null 69.1 Palliative (P) 2014-01-04 2014-01-16 FIGARO TRIAL 02 Y 220036733 ARSENIC TRIOXIDE + ATRA
220018199 220009673 null null Palliative (P) 2017-07-18 2018-06-26 Cytarabine+Methotrexate Intrathecal N N 220036750 BUSULFAN + FLUDARABINE
220018200 220009675 1.69 72.6 null 2013-05-02 2013-05-02 CODOX M N N 220036755 GCLAC
220018201 220009677 1.72 73 Palliative (P) null 2018-09-12 INTERFERON 02 N 220036760 MERCAPTOPURINE
220018202 220009680 null null null 2013-07-27 2013-08-15 ALL UKALL2011 Ind A Sht Dex (PAsp) null N 220000653 ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE + MELPHALAN
220018203 220020004 1.57 56.5 Adjuvant (A) 2016-03-20 2016-04-17 LENALIDOMIDE N N 220002814 CETUXIMAB + CISPLATIN + FU
220018204 220009687 1.7 57 Palliative (P) 2016-05-21 2016-09-07 CODOX M 2 N 220003896 BUSULPHAN + CYCLO
220018205 220009689 1.67 78.4 null 2016-09-26 2016-10-06 Arsenic Triox + Tretinoin Ind W1-4 02 N 220004682 CAPECITABINE + IRINOTECAN
220018206 220009693 null 51.1 Palliative (P) null 2017-05-09 ALL UKALL2011 TRIAL N N 220004682 DACARBAZINE
220018207 220015116 null null Neo-adjuvant (N) 2018-06-08 2018-06-13 Alemtuzumab + Cyclophos TBI Allo null null 220006910 MELPHALAN
220018208 220009696 1.62 null Disease modification (D) 2015-07-03 2015-07-03 Capecitabine N N 220009544 MACE
220018209 220009698 1.65 61.7 Palliative (P) 2016-07-03 2016-07-09 Cisplatin + Pemetrexed 2 N 220011016 CISPLATIN + DOCETAXEL + FLUOROURACIL
220018210 220009700 1.62 116.3 Palliative (P) 2018-08-03 2018-08-08 FIGARO TRIAL N null 220014128 EOX
220018211 220009703 -1 null Disease modification (D) null 2015-10-11 Capecitabine null N 220014221 MELPHALAN
220018212 220018243 1.64 75 Disease modification (D) 2018-05-13 2018-05-27 Capecitabine N N 220016525 MITOXANTRONE + TRETINOIN
220018213 220009708 1.66 127 null 2016-12-29 2016-12-31 Lenalidomide 25mg (Cycle 1 to 25) N N 220017507 FIGARO TRIAL
220018214 220015125 1.68 null Disease modification (D) 2013-10-26 2014-03-30 Methotrexate High Dose (3g/m2) null N 220017673 CYTARABINE + FLUDARABINE
220018215 220009713 1.61 78.4 Disease modification (D) 2017-10-14 2018-04-01 Irinotecan N N 220018242 CETUXIMAB + CISPLATIN + FU
220018216 220009723 null 84.3 Curative (C) 2017-07-07 2017-12-25 Alemtuzumab + Cyclophos TBI Allo null null 220020424 CYTARABINE IT + METHOTREXATE